PGC1α/β Expression Predicts Therapeutic Response to Oxidative Phosphorylation Inhibition in Ovarian Cancer

作者
Carmen Ghilardi,Catarina Moreira-Barbosa,Laura Brunelli,Paola Ostano,Nicolò Panini,Monica Lupi,Alessia Anastasia,Fabio Fiordaliso,Monica Salio,Laura Formenti,Massimo Russo,Edoardo Arrigoni,Ferdinando Chiaradonna,Giovanna Chiorino,Giulio Francesco Draetta,Joseph R. Marszalek,Christopher P. Vellano,Roberta Pastorelli,Maria Rosa Bani,Alessandra Decio
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:82 (7): 1423-1434 被引量:37
标识
DOI:10.1158/0008-5472.can-21-1223
摘要

Ovarian cancer is the deadliest gynecologic cancer, and novel therapeutic options are crucial to improve overall survival. Here we provide evidence that impairment of oxidative phosphorylation (OXPHOS) can help control ovarian cancer progression, and this benefit correlates with expression of the two mitochondrial master regulators PGC1α and PGC1β. In orthotopic patient-derived ovarian cancer xenografts (OC-PDX), concomitant high expression of PGC1α and PGC1β (PGC1α/β) fostered a unique transcriptional signature, leading to increased mitochondrial abundance, enhanced tricarboxylic acid cycling, and elevated cellular respiration that ultimately conferred vulnerability to OXPHOS inhibition. Treatment with the respiratory chain complex I inhibitor IACS-010759 caused mitochondrial swelling and ATP depletion that consequently delayed malignant progression and prolonged the lifespan of high PGC1α/β-expressing OC-PDX-bearing mice. Conversely, low PGC1α/β OC-PDXs were not affected by IACS-010759, thus pinpointing a selective antitumor effect of OXPHOS inhibition. The clinical relevance of these findings was substantiated by analysis of ovarian cancer patient datasets, which showed that 25% of all cases displayed high PGC1α/β expression along with an activated mitochondrial gene program. This study endorses the use of OXPHOS inhibitors to manage ovarian cancer and identifies the high expression of both PGC1α and β as biomarkers to refine the selection of patients likely to benefit most from this therapy. SIGNIFICANCE: OXPHOS inhibition in ovarian cancer can exploit the metabolic vulnerabilities conferred by high PGC1α/β expression and offers an effective approach to manage patients on the basis of PGC1α/β expression.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
1秒前
1秒前
1秒前
勤恳幻姬完成签到 ,获得积分10
1秒前
1秒前
1秒前
1秒前
1秒前
1秒前
1秒前
SSSDEFEFGG发布了新的文献求助10
2秒前
2秒前
呼呼哈哈完成签到 ,获得积分10
3秒前
4秒前
秀丽天川发布了新的文献求助10
4秒前
5秒前
Shauna完成签到,获得积分10
5秒前
6秒前
花九发布了新的文献求助10
6秒前
Whisper完成签到 ,获得积分10
7秒前
7秒前
顾矜的应助被辛勤泥猴桃采纳,获得10
7秒前
初温完成签到 ,获得积分10
8秒前
舒适JIA发布了新的文献求助10
8秒前
赘婿的应助被强风吹拂采纳,获得20
8秒前
8秒前
9秒前
wuxiaoyan426发布了新的文献求助20
9秒前
smzyyd发布了新的文献求助10
10秒前
个性的冬天完成签到 ,获得积分10
10秒前
黎L完成签到,获得积分10
10秒前
CarryLJR发布了新的文献求助10
10秒前
10秒前
11秒前
思源的应助被qq采纳,获得10
12秒前
典雅翅膀发布了新的文献求助10
13秒前
深情安青的应助被wang采纳,获得10
14秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160632
求助须知:如何正确求助?哪些是违规求助? 9555512
关于积分的说明 21728801
捐赠科研通 7750444
什么是DOI,文献DOI怎么找? 3427429
关于科研通互助平台的介绍 2552456
邀请新用户注册赠送积分活动 2471817